Yinfang Wu

Successful response to the combination of immunotherapy and chemotherapy in cholangiocarcinoma with high tumour mutational burden and PD-L1 expression: a case report

Haibo Mou, Lanfang Yu, Qin Liao et al. · BMC Cancer · 2018 · 65 citations · Full text

Medicine, Immunology, Oncology +17

miR-216a-3p Inhibits the Proliferation, Migration, and Invasion of Human Gastric Cancer Cells via Targeting RUNX1 and Activating the NF-κB Signaling Pathway

Yinfang Wu, Jun Zhang, Yu Zheng et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2017 · 32 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

miRNA-93-5p Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Targeting the PTEN-Mediated PI3K/Akt Signaling Pathway.

Yinfang Wu, Weixing Xu, Yueming Yang et al. · PubMed · 2021 · 19 citations

Medicine, Oncology, Pharmacology +17

<i>ING4</i>expressing oncolytic vaccinia virus promotes anti-tumor efficiency and synergizes with gemcitabine in pancreatic cancer

Yinfang Wu, Xiaozhou Mou, Shibing Wang et al. · Oncotarget · 2017 · 16 citations · Full text

Medicine, Oncology, Pharmacology +14

The clinicopathological significance of &lt;em&gt;HES1 &lt;/em&gt;promoter hypomethylation in patients with colorectal cancer

Yinfang Wu, Lijie Gong, Ji Xu et al. · OncoTargets and Therapy · 2017 · 13 citations · Full text

Medicine, Molecular Biology, Oncology +17